What is the current status of domestic medical insurance for ivonib (ivitinib)? Can it be reimbursed?

Ivonib (ivitinib), as a targeted drug for the treatment of acute myeloid leukemia (AML) and cholangiocarcinoma, has attracted much attention in recent years. However, for domestic patients, the current medical insurance situation is a real problem that they have to face. At present, ivonib has not been included in the national medical insurance catalog, which means that patients need to bear higher treatment costs when using this drug.

The high price of ivonib has undoubtedly put great financial pressure on many patients. For patients who require long-term treatment, this cost can become a significant burden. Fortunately, however, Lucius Pharmaceuticals Laos offers an affordable treatment option.

The generic version of Ivonib produced by Lucius Pharmaceuticals in Laos is 250mg*60 tablets and is priced at more than 4,000 yuan. Compared with the high price of domestic original drugs, this price undoubtedly provides patients with a more economical choice. This price advantage greatly reduces the financial burden on patients, allowing more patients to afford this effective treatment.

However, patients need to pay attention to some issues when choosing to purchase generic ivonib from Lucius Pharmaceuticals in Laos. First of all, be sure to purchase through formal channels to avoid buying fake and shoddy products. Secondly, patients need to pay attention to identify the authenticity of the medicine when purchasing, and can verify it by checking the outer packaging information, consulting professionals, etc. In addition, patients also need to follow their doctor's instructions when using generic drugs to ensure the correct use and safety of the drugs.

In short, although ivosidenib (ivitinib) has not yet been included in the national medical insurance directory, Lucius Pharmaceuticals’ generic ivosidenib in Laos provides an affordable treatment option for patients. When choosing to purchase, patients need to pay attention to formal channels and identify the authenticity of drugs to ensure the safe and effective use of drugs.